APO RESEARCH · REPORT
In-Vitro Colorectal Cancer Screening Tests
In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.
Product & engineering
Understand the product.
In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.
Selected research
Market Structure
Global In-Vitro Colorectal Cancer Screening Tests Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.
The industry's leading producers are Alere(Abbott), Beckman Coulter and Siemens Healthcare, which accounted for 31.59%, 18.71% and 10.67% of revenue in 2019, respectively.
Report Includes
Read the full market overview
This report provides an overview of the global In-Vitro Colorectal Cancer Screening Tests market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of In-Vitro Colorectal Cancer Screening Tests and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents In-Vitro Colorectal Cancer Screening Tests revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the In-Vitro Colorectal Cancer Screening Tests market size, projected growth trends, production technologies, key applications, and end-use industries.
In-Vitro Colorectal Cancer Screening Tests Segment by Company
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
In-Vitro Colorectal Cancer Screening Tests Segment by Type
Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
In-Vitro Colorectal Cancer Screening Tests Segment by Application
Hospital and Clinics
Ambulatory
Home Care
In-Vitro Colorectal Cancer Screening Tests Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Colorectal Cancer Screening Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Colorectal Cancer Screening Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Colorectal Cancer Screening Tests.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of In-Vitro Colorectal Cancer Screening Tests in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In-Vitro Colorectal Cancer Screening Tests industry.
Chapter 3: Detailed analysis of In-Vitro Colorectal Cancer Screening Tests companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-Vitro Colorectal Cancer Screening Testsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biomarker Tests
- Fecal Occult Blood Tests
- CRC DNA Screening Tests
Applications
- Hospital and Clinics
- Ambulatory
- Home Care
Companies covered
- Alere(Abbott)
- Beckman Coulter
- Siemens Healthcare
- Eiken Chemical
- Hitachi Chemical (Kyowa Medex)
- Clinical Genomics Pty Ltd (Quest Diagnostics)
- Sysmex
- QIAGEN
- R-Biopharm
- Immunostics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Biomarker Tests
- 1.2.3 Fecal Occult Blood Tests
- 1.2.4 CRC DNA Screening Tests
- 1.3 Market Analysis by Application
- 1.3.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital and Clinics
- 1.3.3 Ambulatory
- 1.3.4 Home Care
- 1.4 Global Market Growth Prospects
- 1.5 Global In-Vitro Colorectal Cancer Screening Tests Growth Trends by Region
- 1.5.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2021-2026)
- 1.5.3 In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global In-Vitro Colorectal Cancer Screening Tests Market Dynamics
- 2.1 In-Vitro Colorectal Cancer Screening Tests Industry Trends
- 2.2 In-Vitro Colorectal Cancer Screening Tests Industry Drivers
- 2.3 In-Vitro Colorectal Cancer Screening Tests Industry Opportunities and Challenges
- 2.4 In-Vitro Colorectal Cancer Screening Tests Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Company (2021-2026)
- 3.2 Global In-Vitro Colorectal Cancer Screening Tests Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global In-Vitro Colorectal Cancer Screening Tests Key Company Head office and Area Served
- 3.4 Global In-Vitro Colorectal Cancer Screening Tests Company, Product Type & Application
- 3.5 Global In-Vitro Colorectal Cancer Screening Tests Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global In-Vitro Colorectal Cancer Screening Tests Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 In-Vitro Colorectal Cancer Screening Tests Players Market Share by Revenue in 2025
- 3.6.3 2025 In-Vitro Colorectal Cancer Screening Tests Tier 1, Tier 2, and Tier 3
4 In-Vitro Colorectal Cancer Screening Tests Market by Type
- 4.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2021-2032)
- 4.3 Global In-Vitro Colorectal Cancer Screening Tests Market Size Share by Type (2021-2032)
5 In-Vitro Colorectal Cancer Screening Tests Market by Application
- 5.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2021-2032)
- 5.3 Global In-Vitro Colorectal Cancer Screening Tests Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Alere(Abbott)
- 6.1.1 Alere(Abbott) Company Information
- 6.1.2 Alere(Abbott) Business Overview
- 6.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 6.1.5 Alere(Abbott) Recent Developments
- 6.2 Beckman Coulter
- 6.2.1 Beckman Coulter Company Information
- 6.2.2 Beckman Coulter Business Overview
- 6.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 6.2.5 Beckman Coulter Recent Developments
- 6.3 Siemens Healthcare
- 6.3.1 Siemens Healthcare Company Information
- 6.3.2 Siemens Healthcare Business Overview
- 6.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 6.3.5 Siemens Healthcare Recent Developments
- 6.4 Eiken Chemical
- 6.4.1 Eiken Chemical Company Information
- 6.4.2 Eiken Chemical Business Overview
- 6.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 6.4.5 Eiken Chemical Recent Developments
- 6.5 Hitachi Chemical (Kyowa Medex)
- 6.5.1 Hitachi Chemical (Kyowa Medex) Company Information
- 6.5.2 Hitachi Chemical (Kyowa Medex) Business Overview
- 6.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 6.5.5 Hitachi Chemical (Kyowa Medex) Recent Developments
- 6.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
- 6.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Information
- 6.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
- 6.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 6.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
- 6.7 Sysmex
- 6.7.1 Sysmex Company Information
- 6.7.2 Sysmex Business Overview
- 6.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Sysmex In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 6.7.5 Sysmex Recent Developments
- 6.8 QIAGEN
- 6.8.1 QIAGEN Company Information
- 6.8.2 QIAGEN Business Overview
- 6.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 QIAGEN In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 6.8.5 QIAGEN Recent Developments
- 6.9 R-Biopharm
- 6.9.1 R-Biopharm Company Information
- 6.9.2 R-Biopharm Business Overview
- 6.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 6.9.5 R-Biopharm Recent Developments
- 6.10 Immunostics
- 6.10.1 Immunostics Company Information
- 6.10.2 Immunostics Business Overview
- 6.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Immunostics In-Vitro Colorectal Cancer Screening Tests Product Portfolio
- 6.10.5 Immunostics Recent Developments
7 North America
- 7.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032)
- 7.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type
- 7.2.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2021-2026)
- 7.2.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2027-2032)
- 7.2.3 North America In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2021-2032)
- 7.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application
- 7.3.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2021-2026)
- 7.3.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2027-2032)
- 7.3.3 North America In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2021-2032)
- 7.4 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country
- 7.4.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
- 7.4.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2027-2032)
- 7.4.4 North America In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032)
- 8.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type
- 8.2.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2021-2026)
- 8.2.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2027-2032)
- 8.2.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2021-2032)
- 8.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application
- 8.3.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2021-2026)
- 8.3.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2027-2032)
- 8.3.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2021-2032)
- 8.4 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country
- 8.4.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
- 8.4.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2027-2032)
- 8.4.4 Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032)
- 9.2 China In-Vitro Colorectal Cancer Screening Tests Market Size by Type
- 9.2.1 China In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2021-2026)
- 9.2.2 China In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2027-2032)
- 9.2.3 China In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2021-2032)
- 9.3 China In-Vitro Colorectal Cancer Screening Tests Market Size by Application
- 9.3.1 China In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2021-2026)
- 9.3.2 China In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2027-2032)
- 9.3.3 China In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032)
- 10.2 Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Type
- 10.2.1 Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2021-2026)
- 10.2.2 Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2027-2032)
- 10.2.3 Asia In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2021-2032)
- 10.3 Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Application
- 10.3.1 Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2021-2026)
- 10.3.2 Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2027-2032)
- 10.3.3 Asia In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2021-2032)
- 10.4 Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Country
- 10.4.1 Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
- 10.4.3 Asia In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2027-2032)
- 10.4.4 Asia In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size (2021-2032)
- 11.2 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type
- 11.2.1 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application
- 11.3.1 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country
- 11.4.1 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst